Latest News

Stay up to date with the latest developments in myasthenia gravis research, advocacy, and community support. Explore news, events, and policy updates to stay informed and get involved.

Browse our categories to explore stories relevant to you, and stay connected with the MG community.

All
  • All
  • About MAA News Items
  • Annual Conference News Items
  • Art With Heart News Items
  • Get Involved News Items
  • Health Professionals News Items
  • Living with MG News Items
  • MG Awareness Month News Items
  • Patient Tool Kit
  • Policy Makers News Items
  • Understanding MG News Items
Updated COVID Booster Advice 2023
February 27, 2023

An update to COVID-19 Booster Vaccination 2023

RITUXIMAB AN UNRESTRICTED LISTING!
September 2, 2022

Rituximab is now an Unrestricted Listing

PatientReportedSurveyMAAImage
Patient reported outcome survey closing soon
January 23, 2022

The Patient Reported Side-Effects Experience Survey is closing soon.

MAA Covid-19 Vaccination Announcement
January 4, 2022

An update to COVID-19 Vaccination

UPDATED – Patient Reported Outcome Survey Progress
December 13, 2021

Take part in Patient Reported Outcome Survey.

Patient Reported Outcome Survey Progress
November 23, 2021

Take part in Patient Reported Outcome Survey.

RITUXIMAB PBS LISTED!
October 20, 2021

Rituximab has now been listed on the Pharmaceutical Benefits Scheme.

Recommendations on the use of a 3rd Primary Dose of COVID-19 Vaccinations for People Severely Immunocompromised
October 12, 2021

Recommendations on the use of a 3rd Primary Dose of COVID-19 Vaccinations for People Severely Immunocompromised

MG PATIENT REPORTED OUTCOME SURVEY
October 8, 2021

The “Myasthenia Gravis Patient Reported Outcome Survey” Research Project is now ready for patient input!

WORK WITH A GREAT TEAM
July 1, 2021

Work with a Great Team!